Henry Schein reports new CEO, 6.3% sales growth, but flags material control changes from M&A

Filed May 5, 2026 · Period ending March 28, 2026 · Compared to 10-Q May 5, 2025 · ~2 min read

Key Changes

• high

  Company reversed stance on internal controls, now stating Q1 2026 acquisitions and system implementations represent a material change—contradicting prior-year assessment that similar activity did not.

  Controls & Procedures verify on EDGAR →
• high

  Frederick M. Lowery appointed CEO effective March 2, 2026, succeeding Stanley M. Bergman who retired after decades leading the company and transitions to Chairman Emeritus post-2026 annual meeting.

  MD&A: Leadership verify on EDGAR →
• high

  Net sales rose 6.3% in Q1 2026 vs. 0.1% decline prior year, driven by 2.5% internal growth, 3.1% FX tailwind, and dental equipment recovery; gross margin expanded to 31.8% from 31.6%.

  MD&A: Sales & Margins verify on EDGAR →